Press releases

RaySearch Laboratories 2005 Annual Report published

As of today, RaySearch Laboratories 2005 Annual Report is available in Swedish and English as a pdf file at the Group’s website The printed versions are under production and will be distributed to the shareholders. For further information: Johan Löf President and CEO, RaySearch Laboratories AB Telephone: +46 (0)8-545 061 30 About RaySearch RaySearch develops and markets software for radiation therapy of cancer. The products are specially designed to optimize radiation therapy with the aim of adapting the radiation dose to the contour of the tumor, which then allows high doses to be delivered to the tumor while minimizing the dose to surrounding healthy tissue. RaySearch, a spin-off from Karolinska Institutet, was formed in 2000. The company has since sold its product RayOptimizer to more than 900 hospitals internationally through a licensing agreement with Philips, thus enabling more than 100,000 patients to receive improved radiation therapy. Sales through Philips of the products RayBiology and RayMachine began in 2004. RaySearch signed a licensing agreement with Nucletron at the beginning of 2004. The latter agreement made RaySearch's products available to a large number of additional clinics worldwide and, consequently, increased the number of potential customers sharply. Delivery to clinics of OM-Optimizer, the first product based on the partnership with Nucletron, began in April 2005. In 2005, RaySearch signed a Letter of Intent with Philips for the development of products within adaptive radiation therapy. In February 2006 an agreement was signed with Scanditronix-Wellhöfer regarding development of products for improved quality assurance for IMRT. RaySearch was listed on the Stockholm Stock Exchange’s O-List in November 2003 and as of July 1, 2005, RaySearch is listed in the Attract40 segment. RaySearch is based in Stockholm and currently has 28 employees. RaySearch Laboratories AB (publ) Sveavägen 25 SE-111 34 Stockholm Telephone: +46 (0)8–545 061 30 Company website: